Fosun-owned Gland Pharma, has come out with fixed price issue to raise Rs 64,795.4 million to fund its  expansion plans. The issue opens on November 9 and closes on November 11.

The company has fixed issue price at Rs 1,490-1,500 a share. The face value of shares is Rs 1 each. It  has put up 34.9 million equity shares on offer under this public issue. The shares will list on both the BSE and the NSE.

Kotak Mahindra Capital Company, Citigroup Global Markets India, Haitong Securities India and Nomura  Financial Advisory and Securities India are the book running lead managers to the issue.